Lv1
72 积分 2021-07-21 加入
Orally Bioavailable Cyclin A/B RxL Inhibitors: Optimization of a Novel Class of Macrocyclic Peptides That Target E2F-High and G1–S-Checkpoint-Compromised Cancers
3天前
已完结
515LBA (PB-515) LBA Posters: CID-078, a first-in-class oral macrocycle cyclin A/B-RxL inhibitor, demonstrates anti-tumor activity in E2F-driven cancers
3天前
已完结
Tunable Two-Compartment On-Demand Sustained Drug Release Based on Lipid Gels
13天前
已完结
Swelling kinetics of mixtures of soybean phosphatidylcholine and glycerol dioleate
25天前
已完结
A liquid crystal in situ gel based on rotigotine for the treatment of Parkinson’s disease
25天前
已完结
Quality by design (QbD) in the formulation and optimization of liquid crystalline nanoparticles (LCNPs): A risk based industrial approach
1个月前
已完结
Lyotropic liquid crystals for parenteral drug delivery
1个月前
已完结
Mesogenic Architectures for Advanced Drug Delivery: Interrogating Lyotropic and Thermotropic Liquid Crystals
1个月前
已完结
Exploiting the potential of in situ forming liquid crystals: development and in vitro performance of long-acting depots for peptide drug thymosin alpha 1 subcutaneous administration
1个月前
已完结
Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD
1个月前
已完结
皖公网安备34019202002308
